Skip to content

Clinical trials

Fatty Liver trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fatty Liver Country / region: Belgium Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20151
20171
20181
20201
20232
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting7
Terminated3
Completed2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
89bio, Inc.2
Sanofi2
Alnylam Pharmaceuticals1
Centre Hospitalier Universitaire Saint Pierre1
Eli Lilly and Company1
Inventiva Pharma1
Julius Clinical1
Newcastle University1
Novartis Pharmaceuticals1
University Hospital, Ghent1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fatty Liver12
Non-alcoholic Fatty Liver Disease8
Digestive System Diseases4
Fibrosis4
Liver Cirrhosis4
Liver Diseases3
Diabetes Mellitus, Type 22
Hypertension2
Metabolic Diseases2
Obesity2

Trials

Showing 51 to 12 of 12. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.